Company news
Biophytis Sa (EURONEXT:ALBPS) news
Every Biophytis Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Biophytis S A : ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
September 11, 2026
Biophytis S A : to evaluate BIO101’s potential to limit weight regain in its OBA clinical study in obesity
September 9, 2026
Biophytis S A : strengthens its financial position and extends its cash runway into Q1 2027
August 31, 2026
Biophytis S A : INFORMATION ON ANNUAL FINANCIAL STATEMENTS
April 29, 2026
Biophytis S A : ANNOUNCES COMPLETION OF OVER €2.0 MILLION CAPITAL INCREASE AND THE REPAYMENT OF ALL VARIABLE PRICE CONVERTIBLE DEBT
March 11, 2026
Biophytis S A : increases to €2 million the ceiling of its bond facility with Hexagon Capital Fund
February 27, 2026
Biophytis S A : conclut un accord stratégique en Asie et sécurise 20 M$ pour le lancement de sa Phase 3 dans la sarcopénie
January 28, 2026
Biophytis S A : enters strategic agreement in Asia and secures $20 million for launch of Phase 3 trial in sarcopenia
January 28, 2026
Biophytis S A : All resolutions presented by the Company have been adopted Biophytis announces the approval of all the resolutions presen...
November 13, 2025
Biophytis S A : Reports First-Half 2025 Results and Provides Strategic Update
October 30, 2025
Biophytis S A : dévoile les résultats du premier semestre 2025 et fait le point sur sa stratégie
October 30, 2025
Biophytis S A : and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase ...
October 13, 2025
Biophytis S A : Secures public funding in Brazil for Obesity Phase 2 Trial and Signs Agreements with Leading local Clinical Partners
September 15, 2025
Biophytis S A : obtient un financement public au Brésil pour l’essai de Phase 2 dans l’obésité et signe des accords avec des centres clin...
September 15, 2025
Biophytis S A : unveils Phase 3 Sarcopenia Trial Strategy with BIO101 in Europe and Asia
September 11, 2025
Biophytis S A : obtains EMA authorization to launch its Phase 2 clinical trial in obesity
September 3, 2025
Biophytis S A : obtient l'autorisation de l'EMA pour le lancement de son étude clinique de phase 2 dans l’obésité
September 3, 2025